相关实验视频

Updated: Jun 18, 2026

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

22.4K

使用非向代谢组的初级甲状腺功能障碍症的新见解.

Marta Wielogórska-Partyka1, Joanna Godzien2, Beata Podgórska-Golubiewska1

  • 1Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276, Białystok, Poland.

Scientific reports
|September 9, 2024
PubMed
概括

初级甲状腺功能障碍症 (PHPT) 涉及过多的甲状腺激素 (PTH) 和不平衡. 代谢学揭示了PHPT患者的不同代谢概况,将特定的代谢物与心血管问题和骨密度降低等并发症联系起来.

关键词:
骨矿物质密度 骨矿物质密度是一种主要的副甲状腺功能障碍症.没有针对性的代谢组分.

更多相关视频

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells08:28

Author Spotlight: Advancing Metabolomics Analysis of Rare Hematopoietic Stem Cells

Published on: February 23, 2024

1.8K
Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics11:02

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

494

相关概念视频

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...